Genomics costing tool
World Health Organization
Related document (user manual): · 2026-03
Abstract
The second edition of the Genomics Costing Tool builds on the first version, which focused on SARS-CoV-2, by enabling costing for a broader range of viral and bacterial pathogens. Developed by WHO in collaboration with the Association of Public Health Laboratories, FIND, and the UK Health Security Agency, this edition features an expanded list of sequencing platforms and reagents and is designed to remain adaptable as pathogen and technology needs evolve.
The GCT is a Microsoft Excel–based interactive tool designed to support data collection, cost estimation, and interpretation of outputs for financial planning and resource mobilization across genomic surveillance systems. It is intended for policymakers, health administrators and economists, laboratory leaders, quality managers, donor institutions, and other stakeholders involved in sequencing and bioinformatics for priority pathogens.
The detailed user manual is available as a separate document.
MeSH terms
- Genomics
- High-Throughput Nucleotide Sequencing
- Public Health Surveillance
- Computational Biology
- Viruses
- Bacteria
- Influenza, Human
- Mycobacterium tuberculosis
- SARS-CoV-2
- Costs and Cost Analysis
- Data Collection
- Health Care Costs
- Financial Management
- Resource Allocation
- Equipment and Supplies
- Laboratories
- Personnel Staffing and Scheduling
- Health Workforce
- Containment of Biohazards
- Quality Control
- Software
- User-Computer Interface
- economics
- methods